These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 6245712)
1. Binding of adenosine diphosphate to human blood platelets and to isolated blood platelet membranes. Lips JP; Sixma JJ; Schiphorst ME Biochim Biophys Acta; 1980 Apr; 628(4):451-67. PubMed ID: 6245712 [TBL] [Abstract][Full Text] [Related]
2. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets. Macfarlane DE; Srivastava PC; Mills DC J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277 [TBL] [Abstract][Full Text] [Related]
3. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities. Legrand C; Dubernard V; Caen J Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225 [TBL] [Abstract][Full Text] [Related]
4. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets. Lam SC; Guccione MA; Packham MA; Mustard JF Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543 [TBL] [Abstract][Full Text] [Related]
5. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets. Hall DA; Hourani SM Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360 [TBL] [Abstract][Full Text] [Related]
6. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase. Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276 [TBL] [Abstract][Full Text] [Related]
7. The effect of ADP, calcium and some inhibitors of platelet aggregation on protein phosphokinases from human blood platelets. Bishop GA; Rozenberg MC Biochim Biophys Acta; 1975 Mar; 384(1):112-9. PubMed ID: 165830 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of phospholipase D in rabbit platelet membranes by nucleoside triphosphates and by phosphocreatine: roles of membrane-bound GDP, nucleoside diphosphate kinase and creatine kinase. Fan XT; Sherwood JL; Haslam RJ Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):701-9. PubMed ID: 8192658 [TBL] [Abstract][Full Text] [Related]
9. Interaction of adenosine and adenylnucleotides with the human platelet membrane. Further characterization of the ADP binding sites. Bauvois B; Legrand C; Caen JP Haemostasis; 1980; 9(2):92-104. PubMed ID: 7358322 [TBL] [Abstract][Full Text] [Related]
10. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. Plow EF; Marguerie GA J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495 [TBL] [Abstract][Full Text] [Related]
11. Role of extracellular ATP metabolism in regulation of platelet reactivity. Birk AV; Broekman MJ; Gladek EM; Robertson HD; Drosopoulos JH; Marcus AJ; Szeto HH J Lab Clin Med; 2002 Sep; 140(3):166-75. PubMed ID: 12271274 [TBL] [Abstract][Full Text] [Related]
13. The mechanism of adenosine diphosphate induced platelet aggregation: binding to platelet receptors and inhibition of binding and aggregation by prostaglandin E 1 . Boullin DJ; Green AR; Price KS J Physiol; 1972 Mar; 221(2):415-26. PubMed ID: 5020984 [TBL] [Abstract][Full Text] [Related]
14. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate. Hourani SM; Hall DA; Nieman CJ Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134 [TBL] [Abstract][Full Text] [Related]
15. Interaction of 3'-O-(1-naphthoyl)adenosine 5'-diphosphate, a fluorescent adenosine 5'-diphosphate analogue, with the adenosine 5'-diphosphate/adenosine 5'-triphosphate carrier protein in the mitochondrial membrane. Block MR; Lauquin GJ; Vignais PV Biochemistry; 1982 Oct; 21(22):5451-7. PubMed ID: 7171567 [TBL] [Abstract][Full Text] [Related]
16. Binding of adenosine diphosphate to intact human platelets. Born GV; Feinberg H J Physiol; 1975 Oct; 251(3):803-16. PubMed ID: 1185683 [TBL] [Abstract][Full Text] [Related]
17. Arachidonate metabolism, 5-hydroxytryptamine release and aggregation in human platelets activated by palmitaldehyde acetal phosphatidic acid. Brammer JP; Maguire MH Br J Pharmacol; 1984 May; 82(1):61-72. PubMed ID: 6428500 [TBL] [Abstract][Full Text] [Related]
18. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors. Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464 [TBL] [Abstract][Full Text] [Related]
19. Identification of high-affinity (Kd 0.35 mumol/L) and low-affinity (Kd 7.9 mumol/L) platelet binding sites for ADP and competition by ADP analogues. Jefferson JR; Harmon JT; Jamieson GA Blood; 1988 Jan; 71(1):110-6. PubMed ID: 3334892 [TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]-2-methylthio ADP to rat platelets--effect of clopidogrel and ticlopidine. Savi P; Laplace MC; Maffrand JP; Herbert JM J Pharmacol Exp Ther; 1994 May; 269(2):772-7. PubMed ID: 8182545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]